Oracle stock falls as weak momentum persists despite positive product news

Oracle stock falls as weak momentum persists despite positive product news
Oracle slides 4.13% today to $123.76

Oracle (ORCL) stock is trading at $123.76, down 4.13% on the day and closing near its session lows. The price currently sits below its key moving averages, highlighting ongoing downward momentum.

ORCL price prediction
24H -1.01%
$118.15
48H -1.6%
$117.44
7D -4.19%
$114.35
1M -5.65%
$112.61
3M -28.48%
$85.36
6M -46.91%
$63.36
12M -49.57%
$60.19
Current price: $119.35 -11.3900 8.71%
Closed 11/02
Daily range 118.49 Arrow from to Icon 124.89
Weekly range 118.49 Arrow from to Icon 148.40
Loading...

Highlights

  • Oracle patched 1,295 security flaws in its October update, addressing critical vulnerabilities and reducing operational and reputational risks.
  • Southwest General and Allcargo Logistics reported efficiency gains and faster processes after integrating Oracle Health and Oracle Fusion Cloud Applications.
  • Shares of Oracle fell 4.13% to $123.76, trading under key moving averages with strong bearish momentum and a projected range of $120.68 to $126.84.

Reputational gains and customer wins offset by persistent selling pressure

Oracle’s October security update, which patched 1,295 flaws including a critical unauthenticated vulnerability in its E-Business Suite, addressed key operational and reputational risks, according to Cybersecuritynews. This action improves the company’s product credibility and may reduce future liability, though such updates are viewed as standard practice and do not offer immediate upside to price action. Additionally, Oracle saw its Oracle Health and Oracle Fusion Cloud Applications deployed by Southwest General in Ohio to drive integration of clinical and operational systems, as reported by Investing.com, while Allcargo Logistics in India recorded efficiency gains and faster month-end closing after automating finance and procurement with Oracle’s cloud solutions, according to Hdfcsky. Despite these positive developments, price action has remained under broader selling pressure.

Oracle Corporation asset chart
Oracle Corporation price dynamics. Source: TradingView.

Bearish momentum intensifies as multiple indicators flag oversold conditions

ORCL/USD is trading below the MA-20 at $130.65 and the MA-50 at $132.17 on the hourly chart, with the daily MA-200 well above at $159.2. The Ichimoku Kijun sits at $130.85, acting as immediate resistance. Technical indicators further confirm the bearish setup—MACD and ADX both indicate a persistent downtrend, while RSI at 37.9, together with Stoch RSI, CCI, and Bull/Bear Power, all highlight oversold or seller-dominated conditions. The Awesome Oscillator also aligns with ongoing negative momentum, consistent with weak price action and moderate intraday volatility.

Downside risk prevails as volatility band confines near-term movement

In the near term, ORCL is expected to remain within a $120.68 to $126.84 volatility band. The probability of a move higher is currently very low, while the risk of further declines is elevated unless immediate resistance is reclaimed. Price action is likely to stabilize within this corridor over the next 2–3 trading days. A bullish reversal would require a clear breakout above the Kijun level, while a push below support could open the path toward the range’s lower boundary.

Anton Kharitonov, expert at Traders Union, notes Oracle stock remains under significant selling pressure, with price action rejecting all major moving averages and key technical signals still negative. He observes that while Oracle’s security update and new client wins in healthcare and logistics demonstrate operational strength, these factors have not translated into price stabilization. Downside risks dominate unless $130.85 is reclaimed as resistance. "Until Oracle breaks above the Kijun level, any bullish scenario is off the table — for now, the technical picture remains decidedly negative."

Previously it was reported that Oracle continued to face technical headwinds and downside risks despite initiatives to expand its healthcare technology footprint. The current article reinforces this cautious outlook, emphasizing that the prevailing downside bias remains in place, with sustained pressure likely until Oracle can decisively reclaim immediate resistance near the Ichimoku Kijun level.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.